Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Merck & Co. Inc.

NYS: MRK

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Merck & Co. Inc.

Countdown to close

MRK
/zigman2/quotes/209956077/composite

$

104.60

Change

-0.94 -0.89%

Volume

Volume 3.67m

Mar 22, 2023, 3:55 p.m.

Real time quotes

/zigman2/quotes/209956077/composite

Previous close

$ 105.54

$ 104.60

Change

-0.94 -0.89%

Day low

Day high

$104.46

$106.00

Open
Open: 105.47

52 week low

52 week high

$79.23

$115.49

Open

Market cap

$267.92B

Average volume

9.20M

P/E ratio

18.36

Rev. per Employee

$847,435

EPS

5.71

Dividend

0.73

Div yield

2.78%

Ex dividend date

3/14/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrk

MarketWatch News on MRK

  2. Pfizer Rolls the Dice on Seagen in $43 Billion Deal. The Risks It Faces.

    10:07 a.m. March 13, 2023

    - Josh Nathan-Kazis

  3. Johnson & Johnson, Kellogg, and 2 Other Spinoffs to Watch

    1:15 a.m. March 10, 2023

    - Nicholas Jasinski

  6. Barron’s 100 Most Sustainable U.S. Companies

    5:56 p.m. March 3, 2023

    - Lauren Foster

  7. Biotech Has Fallen Hard. Now Could Be a Good Time to Buy.

    1:00 a.m. March 2, 2023

    - Lewis Braham

  8. The 20 worst U.S. stocks in February: the biggest loser dropped 35%

    6:06 a.m. March 1, 2023

    - Philip van Doorn

  9. Moderna's Covid Boom Is Ending. Why the Outlook Isn't All Grim.

    9:03 a.m. Feb. 28, 2023

    - Josh Nathan-Kazis

  10. Pfizer in Talks to Buy Seagen for $30 Billion or More

    10:21 a.m. Feb. 27, 2023

    - Brian Swint

  15. Merck and Ridgeback will appeal decision and request a review of the opinion

    6:53 a.m. Feb. 24, 2023

    - Ciara Linnane

  16. Merck and Ridgeback Biotherapeutics say European regulator has recommending refusing a marketing authorization for their COVID antiviral

    6:53 a.m. Feb. 24, 2023

    - Ciara Linnane

  17. Moderna Earnings Hit by Falling Covid Vaccine Sales

    8:49 a.m. Feb. 23, 2023

    - Callum Keown

  20. Biosimilar Pricing Looks a Mess. Why Costly Drugs Prevail.

    6:48 p.m. Feb. 21, 2023

    - Josh Nathan-Kazis

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrk

Other News on MRK

  2. Pfizer Agrees to Buy Seagen for $43 Billion

    3:06 p.m. March 13, 2023

    - Jared S. Hopkins

  3. Pfizer Overpays for Seagen, but Who’s Counting

    1:37 p.m. March 13, 2023

    - David Wainer

  5. Seagen’s Cancer Therapy Is Making It a Takeover Target

    12:29 p.m. March 6, 2023

    - Jared S. Hopkins

  6. New Diabetes Drugs Like Ozempic Are Changing How Patients Are Treated

    5:30 a.m. March 5, 2023

    - Ariana Perez-Castells

  7. The Most-Sold Guru Stocks of the 4th Quarter

    9:12 a.m. March 3, 2023

    - GuruFocus.com

  9. Trust Investment Advisors Buys 2, Sells 3 in 4th Quarter

    12:00 p.m. Feb. 28, 2023

    - GuruFocus.com

  10. Pfizer Is Eyeing a Deal With Seagen After Merck's Failure

    2:08 p.m. Feb. 27, 2023

    - GuruFocus.com

  11. Pfizer Is in Early-Stage Talks to Acquire Seagen

    9:56 p.m. Feb. 26, 2023

    - Jared S. Hopkins

  12. 10-K: MERCK & CO., INC.

    4:51 p.m. Feb. 24, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  13. Moderna’s Earnings, Revenue Fall on Fewer Vaccine Sales

    10:27 p.m. Feb. 23, 2023

    - Peter Loftus

  14. America Is Losing the ‘Epic Battle’ Against Bird Flu

    9:21 a.m. Feb. 23, 2023

    - Patrick Thomas

  15. Top 5 4th Quarter Trades of Beutel, Goodman & Co Ltd.

    6:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  16. Nuveen Asset Management, LLC Buys 2, Sells 3 in 4th Quarter

    2:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  17. Mark Hillman Buys 3, Sells 2 in 4th Quarter

    6:00 p.m. Feb. 15, 2023

    - GuruFocus.com

  18. Robert Bruce Buys 1, Sells 4 in 4th Quarter

    12:00 p.m. Feb. 15, 2023

    - GuruFocus.com

  19. Top 5 4th Quarter Trades of NATIXIS

    2:00 a.m. Feb. 15, 2023

    - GuruFocus.com

  20. Top 5 4th Quarter Trades of BAROMETER CAPITAL MANAGEMENT INC.

    10:00 p.m. Feb. 14, 2023

    - GuruFocus.com

  21. Loading more headlines...
/news/pressrelease/company/us/mrk

Press Releases on MRK

  5. Cano Health Inc (NYSE:CANO) could be a sleeping giant and here’s why

    8:20 a.m. March 20, 2023

    - Investor Brand Media

  7. Cano Health Inc (NYSE:CANO): A Potential Investment Opportunity?

    7:31 a.m. March 20, 2023

    - Investor Brand Media

  9. Pulmonary Fibrosis Drugs Market Size, Share, Forecast, 2020-2028

    1:38 a.m. March 17, 2023

    - AmericaNewsHour

  14. Merck $MRK Trading Report

    12:02 p.m. March 14, 2023

    - Stock Traders Daily

  18. Dow Movers: AXP, MRK

    11:38 a.m. March 10, 2023

    - MarketNewsVideo.com

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.